You are here

biosimilars

Second biosimilar of Remicade approved in the US, but J&J not rattled

BioPharma Dive

Mon, 04/24/17 - 10:02 pm

Samsung Bioepis

10 Reasons Merck Could Be the World's Most Perfect Stock

Motley Fool

Fri, 04/21/17 - 11:43 am

J&J's Remicade sees 'very little' biosim erosion, but payers are sticking it to Xarelto

Fierce Pharma

Tue, 04/18/17 - 09:03 pm

4 Reasons Why Roche Will Have the Best Growth in Big Pharma... and 1 Reason Why It Won't

Motley Fool

Wed, 04/12/17 - 10:33 am

HER-2 postive breast cancer

multiple sclerosis

3 Big Biotech Stocks With Big-Time Catalysts

Motley Fool

Sun, 04/9/17 - 12:36 pm

New drugs could save the US billions of dollars — but there's something holding them back

Business Insider

Fri, 04/7/17 - 12:09 am

American-made biosimilars a differentiator in US market, Coherus

Biopharma Reporter

Fri, 03/17/17 - 09:23 am

Coherus Biosciences

Merck KGaA in talks to sell its biosimilars R&D ops as shakeout looms

Endpoints

Thu, 03/9/17 - 11:36 am

Amgen accuses would-be copycat Coherus of stealing its Neulasta secrets

Fierce Pharma

Tue, 03/7/17 - 11:52 am

Coherus Biosciences

Pfizer and Celltrion Seek Biosimilar Interchangeability for Crohn’s Disease Drug

Xtalks

Mon, 02/27/17 - 10:02 pm

Crohn's Disease

Pfizer, Celltrion pushing for interchangeability with Inflectra

BioPharma Dive

Thu, 02/23/17 - 09:11 am

In Amgen-Sandoz SCOTUS case, biosim makers lambaste ruling's 6-month exclusivity gift

Fierce Pharma

Wed, 02/22/17 - 09:44 am

Pfizer's New Biosimilar Is Off and Running

Motley Fool

Sat, 02/4/17 - 10:00 am

rheumatoid arthritis

Amgen Gets EU Nod for Humira Biosimilar

Investopedia

Mon, 01/30/17 - 10:54 pm

New competition took a bite out of J&J’s drug sales, but don’t expect the trend to dominate this earnings season

Marketwatch

Sun, 01/29/17 - 11:57 am

Novartis silently yanks a troubled biosimilar application; Chinese antibody developer draws $39M round

Endpoints

Sun, 01/29/17 - 11:53 am

Biosimilars: What you need to know

BioPharma Dive

Sun, 01/29/17 - 11:43 am

5 hurdles facing biosimilar developers

BioPharma Dive

Sat, 01/28/17 - 02:41 pm

drug development

drug manufacturing

Novartis says court battle will delay its Enbrel copy until 2018 at least

Yahoo/Reuters

Wed, 01/25/17 - 09:58 am

rheumatoid arthritis

Boehringer Ingelheim's Humira Biosimilar Under Review by EMA, FDA

Yahoo/GuruFocus

Fri, 01/20/17 - 09:45 am

Boehringer Ingelheim

Pages